Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cytokine Growth Factor Rev. 2010 Dec;21(6):435-41. doi: 10.1016/j.cytogfr.2010.10.007. Epub 2010 Nov 23.

Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease.

Author information

  • 1Department of Immunology, Genentech, Inc., 1 DNA Way, M/S 34, South San Francisco, CA 94080, USA. ouyang@gene.com

Abstract

IL-22, an IL-10 family cytokine, is produced by different leukocyte subsets, including T cells, NK cells and lymphoid tissue inducer (LTi) cells. IL-22 mediates the crosstalk between leukocytes and tissue epithelia because its receptor is preferentially expressed on various tissue epithelial cells. IL-22 is essential for host defense against infections of extracellular pathogens, such as bacteria and yeasts, by eliciting various innate defensive mechanisms from tissue epithelial cells and promoting wound-healing responses. In autoimmune diseases, however, diverse tissue microenvironments and underlying pathogenic mechanisms may result in opposing contributions of IL-22 in disease progression. For example, in psoriasis, IL-22 can synergize with other proinflammatory cytokines to induce many of the pathogenic phenotypes from keratinocytes and exacerbate disease progression. In contrast, IL-22 plays a beneficial role in IBD by enhancing barrier integrity and epithelial innate immunity of intestinal tract.

Copyright © 2010 Elsevier Ltd. All rights reserved.

PMID:
21106435
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk